<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00549107</url>
  </required_header>
  <id_info>
    <org_study_id>1-365</org_study_id>
    <nct_id>NCT00549107</nct_id>
  </id_info>
  <brief_title>Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants</brief_title>
  <acronym>Levomil</acronym>
  <official_title>Phase 2 Prospective, Randomized, Double-Blind Pilot Study on Cardiac Output Following Corrective Open Heart Surgery in Children Less Than One Year: Use of Levosimendan Versus Milrinone.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig Boltzmann Gesellschaft</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig Boltzmann Gesellschaft</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric patients, especially infants undergoing open heart surgery have a predictable fall
      in cardiac index 6 to 18 hours after surgery, the so-called low cardiac output syndrome
      (LCOS). Patients, who have LCOS require more monitoring, more medication and a longer stay in
      intensive care unit. To prevent LCOS the phosphodiesterase inhibitor milrinone is routinely
      used during the first 24 hours after surgery. Levosimendan, a calcium- sensitizer improves
      cardiac muscle contractile force, vascular smooth muscle relaxation and coronary blood flow
      through calcium sensitization of the myocardial contractile filaments and opening of
      potassium channels without increasing oxygen consumption of the heart muscle cells. As the
      myocardium of infants is more calcium dependent than in later life, levosimendan should be of
      special benefit in this age group. The purpose of this study is to investigate whether
      levosimendan is superior to milrinone in preventing LCOS in infants after corrective open
      heart surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2007</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output measured by a transesophageal probe</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in mixed venous saturation</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lactate levels</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac output and ventricular function assessed by echocardiography</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial, left atrial and central venous pressure</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of catecholamines assessed with the inotropic score</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine output</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Low Cardiac Output Syndrome</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levosimendan</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Milrinone</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age younger than one year

          -  corrective open heart surgery with biventricular repair, except tetralogy of fallot

        Exclusion Criteria:

          -  Missing written consent of parents

          -  Weight less than 3 kg

          -  preoperative LCOS

          -  gestational age less than 36 weeks

          -  preexisting renal failure

          -  preexisting thrombopenia

          -  preoperative cardiopulmonary resuscitation

          -  preoperative use of milrinone or levosimendan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evelyn Lechner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children´s Heart Center Linz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Gombotz, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>General Hospital Linz, Ludwig Boltzmann Gesellschaft</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Hofer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital Linz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerald Tulzer, MD, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Children´s Heart Center Linz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evelyn Lechner, MD</last_name>
    <phone>+43505546324706</phone>
    <email>elechner@aon.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hans Gombotz, MD, PHD</last_name>
    <phone>+4373278062157</phone>
    <email>hans.gombotz@akh.linz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children´s Heart Center Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Lechner, MD</last_name>
      <email>elechner@aon.at</email>
    </contact>
    <contact_backup>
      <last_name>Anna Hofer, MD</last_name>
      <email>anna.hofer@akh.linzat</email>
    </contact_backup>
    <investigator>
      <last_name>Evelyn Lechner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Hofer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castañeda AR, Newburger JW, Wessel DL. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995 Oct 15;92(8):2226-35.</citation>
    <PMID>7554206</PMID>
  </reference>
  <reference>
    <citation>Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003 Feb 25;107(7):996-1002.</citation>
    <PMID>12600913</PMID>
  </reference>
  <reference>
    <citation>Turanlahti M, Boldt T, Palkama T, Antila S, Lehtonen L, Pesonen E. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med. 2004 Sep;5(5):457-62.</citation>
    <PMID>15329162</PMID>
  </reference>
  <reference>
    <citation>Egan JR, Clarke AJ, Williams S, Cole AD, Ayer J, Jacobe S, Chard RB, Winlaw DS. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med. 2006 May-Jun;21(3):183-7.</citation>
    <PMID>16672640</PMID>
  </reference>
  <reference>
    <citation>Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med. 2006 Sep;7(5):445-8. Erratum in: Pediatr Crit Care Med. 2007 Mar;8(2):197.</citation>
    <PMID>16885788</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2007</study_first_submitted>
  <study_first_submitted_qc>October 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2007</study_first_posted>
  <last_update_submitted>October 24, 2007</last_update_submitted>
  <last_update_submitted_qc>October 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2007</last_update_posted>
  <keyword>low cardiac output syndrome</keyword>
  <keyword>open heart surgery</keyword>
  <keyword>infants</keyword>
  <keyword>Low cardiac output syndrome in infants undergoing corrective open heart surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simendan</mesh_term>
    <mesh_term>Milrinone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 2, 2011</submitted>
    <returned>February 25, 2011</returned>
    <submitted>October 22, 2011</submitted>
    <returned>November 28, 2011</returned>
    <submitted>October 13, 2012</submitted>
    <returned>November 14, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

